DiscoveryApril 6, 2021By DDN StaffUsing artificial intelligence to give pharma and biotech a leg upUnique AI method developed at Chalmers for generating proteins could speed up drug development
DiscoveryApril 5, 2021By DDN StaffNew study maps wildlife microbiota for human benefitWild Biotech says it is discovering millions of previously unknown potential human therapeutics
NeuroscienceMarch 30, 2021By DDN StaffDeep brain stimulation for Parkinson's diseaseNew discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment
Tools & Techniques NewsMarch 30, 2021By Broad CommunicationsConnecting biology with machine learningBroad Institute launches the Eric and Wendy Schmidt Center for better understanding programs of life
NeuroscienceMarch 29, 2021By DDN StaffBringing siRNA across the barrierBioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform
NeuroscienceMarch 26, 2021By Jeffrey BouleyFocus Feature on Neuroscience: Preclinical progress on neurodegenerationMaking the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia
Clinical ResearchMarch 26, 2021By GlobalData/DDNews StaffReal world evidence market is growing fastApplications of RWE-based insights range from drug discovery to supporting regulatory decision-making
March 26, 2021By Peter T. KissingerTeaming science while spreading risk—It’s a lottery that worksIt takes real strength of character to accept the high risk in pharma and biotech and not be psychologically crippled by it
March 25, 2021By Ilene SchneiderSynthetic lethal drugs vs. cancerCompany obtains funding to advance precision oncology
March 25, 2021By Mel J. YeatesAdvances in Fabry diseaseAmicus’ engineered hGLA showed greater substrate reduction than wildtype hGLA